GlassScriptPhysician profile
Paul M Gregory
NPI 1609097666
$301.13
in general payments reported to CMS, 2019-2025
9 companies · $80.26 in 2025
The $80.26 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $81.51 · 2023: $103 · 2024: $36.59 · 2025: $80.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $49.55 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.86 | 2025 | Xifaxan |
| Organon LLC | $41.64 | 2022-2023 | Hadlima |
| Takeda Pharmaceuticals U.S.A., INC. | $39.66 | 2022-2024 | Entyvio |
| Janssen Biotech, INC. | $37.02 | 2023-2024 | Stelara |
| Pfizer INC. | $34.40 | 2025 | |
| Mylan Institutional INC. | $19.76 | 2023 | Hulio |
| Regeneron Healthcare Solutions, INC. | $18.50 | 2023 | Dupixent |
| Intercept Pharmaceuticals, INC. | $14.74 | 2023 | Ocaliva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Gregory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.